You are here

  • Home
  • Archive
  • Volume 11, Issue 12
  • Heterogeneity in tertiary lymphoid structures predicts distinct prognosis and immune microenvironment characterizations of clear cell renal cell carcinoma

Article info

Article menu
Immunotherapy biomarkers
Original research
Heterogeneity in tertiary lymphoid structures predicts distinct prognosis and immune microenvironment characterizations of clear cell renal cell carcinoma

Authors

  • Wenhao Xu Department of Urology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of ChinaShanghai Genitourinary Cancer Institute, Shanghai, People's Republic of China PubMed articlesGoogle scholar articles
  • Jiahe Lu Department of Urology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of ChinaShanghai Genitourinary Cancer Institute, Shanghai, People's Republic of ChinaSchool of Cellular and Molecular Medicine, University of Bristol, Bristol, UK PubMed articlesGoogle scholar articles
  • Wang-Rui Liu Department of Interventional Oncology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China PubMed articlesGoogle scholar articles
  • Aihetaimujiang Anwaier Department of Urology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of ChinaShanghai Genitourinary Cancer Institute, Shanghai, People's Republic of China PubMed articlesGoogle scholar articles
  • Yuhao Wu Institute of Photomedicine, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, People's Republic of China PubMed articlesGoogle scholar articles
  • Xi Tian Department of Urology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of ChinaShanghai Genitourinary Cancer Institute, Shanghai, People's Republic of China PubMed articlesGoogle scholar articles
  • Jia-Qi Su Department of Urology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of ChinaShanghai Genitourinary Cancer Institute, Shanghai, People's Republic of China PubMed articlesGoogle scholar articles
  • Yuan-Yuan Qu Department of Urology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of ChinaShanghai Genitourinary Cancer Institute, Shanghai, People's Republic of China PubMed articlesGoogle scholar articles
  • Jianfeng Yang Department of Surgery, ShangNan Branch of Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China PubMed articlesGoogle scholar articles
  • Hailiang Zhang Department of Urology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of ChinaShanghai Genitourinary Cancer Institute, Shanghai, People's Republic of China PubMed articlesGoogle scholar articles
  • Dingwei Ye Department of Urology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of ChinaShanghai Genitourinary Cancer Institute, Shanghai, People's Republic of China PubMed articlesGoogle scholar articles

Citation

Xu W, Lu J, Liu W, et al
Heterogeneity in tertiary lymphoid structures predicts distinct prognosis and immune microenvironment characterizations of clear cell renal cell carcinoma
Journal for ImmunoTherapy of Cancer 2023;11:e006667. doi: 10.1136/jitc-2023-006667
Online issue publication 
December 01, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.